← Back to Patent Explorer
US4748113A Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions and methods for the diagnosis of gastrointestinal disorders involving urease

Assignee: MEDQUEST Pty Ltd
•
Filing: 1985-06-13
•
Granted: 1988-05-31
•
Expires: 2005-06-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compositions for diagnosis of gastrointestinal disorders comprising urea, a bactericide, an indicator having a pK a of from about 6.5 to about 8.5, and water, wherein the composition has a pH of from about 5.0 to about 6.5 and wherein the pH is at least about one pH unit lower than the pK a of the indicator. Preferably the compositions contain a gelling agent, such as agar. Also preferably the composition contain a buffer. The invention also provides methods for diagnosis of gastrointestinal disorders in a human or lower animal subject, comprising the steps of obtaining a sample of gastric material from the subject, contacting the sample with a composition of this invention, and observing any color change, wherein a color change indicates the presence of a gastrointestinal disorder. Also provided are devices for use in diagnosis of gastrointestinal disorders.

Inventors

  • 👤 Barry J. Marshall

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 17:22
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/58; C12Q1/02; C12Q1/04; G; G01; G01N; G01N2333/00; G01N2333/195; G01N2333/205

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 120 words
A composition for the diagnosis of gastrointestinal disorders in a human or lower animal subject by detection of urease in gastric material of the subject, comprising: (a) urea, at a concentration of from about 10 to about 40 grams per liter; (b) a bactericide which substantially inhibits the growth of urease-producing organisms, at a concentration of from about 1 to about 5 grams per liter; (c) an indicator having a pK a of from about 6.5 to about 8.5, at an effective concentration; and (d) water; wherein said composition has a pH of from about 5.0 to about 6.5, and the pH of said composition is at least about one pH unit lower than the pK a of said indicator.
Claim 2
Dependent Claim 120 words
A composition for the diagnosis of gastrointestinal disorders in a human or lower animal subject by detection of urease in gastric material of the subject, comprising: (a) urea, at a concentration of from about 10 to about 40 grams per liter; (b) a bactericide which substantially inhibits the growth of urease-producing organisms, at a concentration of from about 1 to about 5 grams per liter; (c) an indicator having a pK a of from about 6.5 to about 8.5, at an effective concentration; and (d) water; wherein said composition has a pH of from about 5.0 to about 6.5, and the pH of said composition is at least about one pH unit lower than the pK a of said indicator.
Claim 3
Dependent Claim 24 words
A composition, according to claim 1, wherein said indicator is present at a concentration of from about 2 to about 100 milligrams per liter.
Claim 4
Dependent Claim 20 words
A composition, according to claim 2, wherein said indicator has a pK a of from about 7.0 to about 8.0.
Claim 5
Dependent Claim 12 words
A composition, according to claim 3, wherein said indicator is phenol red.
Claim 6
Dependent Claim 19 words
A composition, according to claim 3, wherein said composition has a pH of from about 5.0 to about 6.0.
Claim 7
Dependent Claim 10 words
A composition, according to claim 1, additionally comprising a buffer.
Claim 8
Dependent Claim 24 words
A composition, according to claim 1, additionally comprising a gelling agent, at a concentration of from about 5 to about 50 grams per liter.
Claim 9
Dependent Claim 14 words
A composition, according to claim 7, wherein said gelling agent is a non-nutritive agar.
Claim 10
Dependent Claim 24 words
A composition, according to claim 8, wherein said agar is present at a concentration of from about 10 to about 20 grams per liter.
Claim 11
Independent Claim 157 words
A method for detection of a gastrointestinal disorder in a human or lower animal subject by detection of urease in gastric material of the subject, comprising the steps of: (a) obtaining a sample of gastric material from said subject; (b) contacting said sample with a composition comprising: urea, at a concentration of about 10 to about 40 grams per liter; a bactericide which substantially inhibits the growth of urease-producing organisms, at a concentration of about 1 to about 5 grams per liter; an indicator having a pK a of about 6.5 to about 8.5, at an effective concentration; and water; said composition having a pH of about 5.0 to about 6.5, said pH being about one pH unit less than the pK a of said indicator; and (c) observing the color of said composition; wherein a change of color of said composition indicates the presence of urease and the existence of a gastrointestinal disorder in the subject.
Claim 12
Independent Claim 157 words
A method for detection of a gastrointestinal disorder in a human or lower animal subject by detection of urease in gastric material of the subject, comprising the steps of: (a) obtaining a sample of gastric material from said subject; (b) contacting said sample with a composition comprising: urea, at a concentration of about 10 to about 40 grams per liter; a bactericide which substantially inhibits the growth of urease-producing organisms, at a concentration of about 1 to about 5 grams per liter; an indicator having a pK a of about 6.5 to about 8.5, at an effective concentration; and water; said composition having a pH of about 5.0 to about 6.5, said pH being about one pH unit less than the pK a of said indicator; and (c) observing the color of said composition; wherein a change of color of said composition indicates the presence of urease and the existence of a gastrointestinal disorder in the subject.

References Cited (Backward Citations)

US3145086A Cited
US3247051A Cited
GB1112251A Cited
FR5877M Cited
US4153685A Cited
US3873269A Cited
GB1478742A Cited
US4101382A Cited
US4016268A Cited
FR2442268A1 Cited
EP0018825A1 Cited
US4282316A Cited
JPS5877663A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-05-31 1991-11-30 1992-05-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-05-31 1995-11-30 1996-05-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-05-31 1999-11-30 2000-05-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag